Explore our curated library of peer-reviewed journal publications, white papers, and collaborative reports. Access these open resources through CSRC to gain essential insights that advance cardiovascular science for healthcare professionals, researchers, regulators, and industry leaders.
(click links below to view documents)
- JACC CardioOncology, Cardiovascular Safety in Oncology Clinical Trials Bonaca MP, Lang NN, Chen A, Amiri-Kordestani L, Lipka L, Zwiewka M, et al. Cardiovascular safety in oncology clinical trials: JACC: CardioOncology primer. JACC CardioOncol. 2025 Feb;7(2):83-95. doi:10.1016/j.jaccao.2024.09.014. PMCID:PMC11866450.
- JACC, Remote Monitoring for Cardiac Safety in Clinical Trials Pundi K, Bhavnani S, Adigun R, Vicente J, Ghosh R, Albert D, Al-Siddiq W, Benson C, Fantana A, Goldsack JC, Idriss SF, Marcus G, Tenaerts P, Turakhia MP, Seltzer J. Cardiovascular Sciences Research Consortium Think Tank: Remote Monitoring for Cardiac Safety in Clinical Trials. JACC Adv. 2025 Sep;4(9):102059. doi: 10.1016/j.jacadv.2025.102059. Epub 2025 Aug 8. PMID: 40782682; PMCID: PMC12356306.
- Cardiovascular Safety in Oncology Clinical Trials Bonaca MP, Lang NN, Chen A, Amiri-Kordestani L, Lipka L, Zwiewka M, et al. Cardiovascular safety in oncology clinical trials: JACC: CardioOncology primer. JACC CardioOncol. 2025 Feb;7(2):83-95. doi:10.1016/j.jaccao.2024.09.014. PMID:39967209; PMCID:PMC11866450.
- The COVID-19 pandemic and cardiovascular issues in clinical trials: Practical and regulatory issues in remote monitoring of cardiac safety. Seltzer J, Senatore F, Faulkner K, Stein KM, Browning LS, Voloshko P, Papadopoulos EJ. Am Heart J. 2022 Jan;243:122-126. doi: 10.1016/j.ahj.2021.09.005. Epub 2021 Sep 20. PMID: 34555331 Free PMC article. Review. No abstract available.
- Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week. Januzzi JL Jr, Canty JM, Das S, DeFilippi CR, Gintant GA, Gutstein DE, Jaffe A, Kaushik EP, Leptak C, Mehta C, Pina I, Povsic TJ, Rambaran C, Rhyne RF, Salas M, Shi VC, Udell JA, Unger EF, Zabka TS, Seltzer JH. J Am Coll Cardiol. 2021 Apr 20;77(15):1922-1933. doi: 10.1016/j.jacc.2021.02.040. PMID: 33858628 Free article. Review.
- Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock. Samsky MD, Krucoff MW, Morrow DA, Abraham WT, Aguel F, Althouse AD, Chen E, Cigarroa JE, DeVore AD, Farb A, Gilchrist IC, Henry TD, Hochman JS, Kapur NK, Morrow V, Ohman EM, O'Neill WW, Piña IL, Proudfoot AG, Sapirstein JS, Seltzer JH, Senatore F, Shinnar M, Simonton CA, Tehrani BN, Thiele H, Truesdell AG, Waksman R, Rao SV. Am Heart J. 2020 Dec;230:93-97. doi: 10.1016/j.ahj.2020.09.015. Epub 2020 Oct 2. PMID: 33011148 Free PMC article. No abstract available.
- Defining the path ahead for NOAC use in the pediatric population: A CardiacSafety Research Consortium Think Tank. Seltzer JH, Farrell A, Goldenberg N, Hornik C, Keene D, Krucoff MW, Lipardi C, Massicotte P, Mentzer D, Monagle P, Thornburg C, Revkin JH, Walker S, Gajjar D. Am Heart J. 2020 Jun;224:138-147. doi: 10.1016/j.ahj.2020.02.012. Epub 2020 Feb 28. PMID: 32388153 Free article. Review. No abstract available.
- How to Prescribe Drugs With an Identified Proarrhythmic Liability. Thind M, Rodriguez I, Kosari S, Turner JR. J Clin Pharmacol. 2020 Mar;60(3):284-294. doi: 10.1002/jcph.1551. Epub 2019 Nov 19. PMID: 31743455
- General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy. Li Z, Mirams GR, Yoshinaga T, Ridder BJ, Han X, Chen JE, Stockbridge NL, Wisialowski TA, Damiano B, Severi S, Morissette P, Kowey PR, Holbrook M, Smith G, Rasmusson RL, Liu M, Song Z, Qu Z, Leishman DJ, Steidl-Nichols J, Rodriguez B, Bueno-Orovio A, Zhou X, Passini E, Edwards AG, Morotti S, Ni H, Grandi E, Clancy CE, Vandenberg J, Hill A, Nakamura M, Singer T, Polonchuk L, Greiter-Wilke A, Wang K, Nave S, Fullerton A, Sobie EA, Paci M, Musuamba Tshinanu F, Strauss DG. Clin Pharmacol Ther. 2020 Jan;107(1):102-111. doi: 10.1002/cpt.1647. Epub 2019 Nov 10. PMID: 31709525 Free PMC article.
- Assessing cardiac safety in oncology drug development. Seltzer JH, Gintant G, Amiri-Kordestani L, Singer J, Koplowitz LP, Moslehi JJ, Barac A, Yu AF. Am Heart J. 2019 Aug;214:125-133. doi: 10.1016/j.ahj.2019.04.010. Epub 2019 May 4. PMID: 31202099 Free PMC article. Review. No abstract available.
- Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. Samsky M, Krucoff M, Althouse AD, Abraham WT, Adamson P, Aguel F, Bilazarian S, Dangas GD, Gilchrist IC, Henry TD, Hochman JS, Kapur NK, Laschinger J, Masters RG, Michelson E, Morrow DA, Morrow V, Ohman EM, Pina I, Proudfoot AG, Rogers J, Sapirstein J, Senatore F, Stockbridge N, Thiele H, Truesdell AG, Waksman R, Rao S. Am Heart J. 2020 Jan;219:1-8. doi: 10.1016/j.ahj.2019.10.006. Epub 2019 Nov 7. PMID: 31707323 Free PMC article. Review. No abstract available.
- Research implications of the FDA ECG warehouse and related resources. Green CL. J Electrocardiol. 2019 Nov-Dec;57S:S27-S33. doi: 10.1016/j.jelectrocard.2019.09.009. Epub 2019 Sep 7. PMID: 31627942 Review.
- The Potential Role of the J-T(peak) Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium. Vicente J, Strauss DG, Upreti VV, Fossler MJ, Sager PT, Noveck R. J Clin Pharmacol. 2019 Jul;59(7):909-914. doi: 10.1002/jcph.1411. Epub 2019 Mar 25. PMID: 30907981 No abstract available.
- Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a CardiacSafety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting. Strauss DG, Gintant G, Li Z, Wu W, Blinova K, Vicente J, Turner JR, Sager PT. Ther Innov Regul Sci. 2019 Jul;53(4):519-525. doi: 10.1177/2168479018795117. PMID: 30157676
- A Path Forward for Regenerative Medicine. Fanaroff AC, Morrow V, Krucoff MW, Seltzer JH, Perin EC, Taylor DA, Miller LW, Zeiher AM, Fernández-Avilés F, Losordo DW, Henry TD, Povsic TJ. Circ Res. 2018 Aug 3;123(4):495-505. doi: 10.1161/CIRCRESAHA.118.313261. PMID: 30355250 Review.
- The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium. Aziz PF, Berger S, Kowey P, Krucoff M, Lopez-Anderson M, Michelson E, Molossi S, Morrow V, Rodriguez I, Saarel TE, Strnadova C, Vetter V, Wright TJ, Idriss SF. Am Heart J. 2018 Aug;202:104-108. doi: 10.1016/j.ahj.2018.05.011. Epub 2018 May 23. PMID: 29920452
- Drug-induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy. Turner JR, Rodriguez I, Mantovani E, Gintant G, Kowey PR, Klotzbaugh RJ, Prasad K, Sager PT, Stockbridge N, Strnadova C; Cardiac Safety Research Consortium. J Clin Pharmacol. 2018 Aug;58(8):997-1012. doi: 10.1002/jcph.1129. Epub 2018 Apr 19. PMID: 29672845 Review.
- Comparison of automated interval measurements by widely used algorithms in digital electrocardiographs. Kligfield P, Badilini F, Denjoy I, Babaeizadeh S, Clark E, De Bie J, Devine B, Extramiana F, Generali G, Gregg R, Helfenbein E, Kors J, Leber R, Macfarlane P, Maison-Blanche P, Rowlandson I, Schmid R, Vaglio M, van Herpen G, Xue J, Young B, Green CL. Am Heart J. 2018 Jun;200:1-10. doi: 10.1016/j.ahj.2018.02.014. Epub 2018 Feb 26. PMID: 29898835
- Drug-induced cardiac abnormalities in premature infants and neonates. Pesco-Koplowitz L, Gintant G, Ward R, Heon D, Saulnier M, Heilbraun J. Am Heart J. 2018 Jan;195:14-38. doi: 10.1016/j.ahj.2017.07.014. Epub 2017 Jul 31. PMID: 29224642 Review.
- Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association-cardiac safety research consortium cosponsored think tank. Seifert HA, Malik RE, Bhattacharya M, Campbell KR, Okun S, Pierce C, Terkowitz J, Turner JR, Krucoff MW, Powell GE. Am Heart J. 2017 Dec;194:107-115. doi: 10.1016/j.ahj.2017.08.021. Epub 2017 Sep 4. PMID: 29223428 Review.
- Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium. Seltzer JH, Heise T, Carson P, Canos D, Hiatt JC, Vranckx P, Christen T, Cutlip DE. Am Heart J. 2017 Aug;190:76-85. doi: 10.1016/j.ahj.2017.05.009. Epub 2017 May 28. PMID: 28760216 Review.
- Prevention of sudden cardiac death in the young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac SafetyResearch Consortium. Idriss SF, Berger S, Harmon KG, Kindman A, Kleiman R, Lopez-Anderson M, Molossi S, Saarel TE, Strnadova C, Todaro T, Shinagawa K, Morrow V, Krucoff M, Vetter V, Wright TJ. Am Heart J. 2017 Aug;190:123-131. doi: 10.1016/j.ahj.2017.05.003. Epub 2017 May 18. PMID: 28760206 Review.
- Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium. Piccini JP, Clark RL, Kowey PR, Mittal S, Dunnmon P, Stockbridge N, Reiffel JA, Turakhia MP, Ziegler PD, Kleiman RB, Ismat F, Sager P. Am Heart J. 2017 May;187:156-169. doi: 10.1016/j.ahj.2017.01.012. Epub 2017 Jan 26. PMID: 28454799 Review.
- The Cardiac Safety Research Consortium enters its second decade: An invitation to participate. Turner JR, Kowey PR, Rodriguez I, Cabell CH, Gintant G, Green CL, Kunz BL, Mortara J, Sager PT, Stockbridge N, Wright TJ, Finkle J, Krucoff MW; Cardiac Safety Research Consortium. Am Heart J. 2016 Jul;177:96-101. doi: 10.1016/j.ahj.2016.04.009. Epub 2016 Apr 23. PMID: 27297854 Review.
- NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank. Reiffel JA, Weitz JI, Reilly P, Kaminskas E, Sarich T, Sager P, Seltzer J; Cardiac Safety Research Consortium presenters and participants. Am Heart J. 2016 Jul;177:74-86. doi: 10.1016/j.ahj.2016.04.010. Epub 2016 Apr 23. PMID: 27297852 Review.
- Recent developments in using mechanistic cardiac modelling for drug safety evaluation. Davies MR, Wang K, Mirams GR, Caruso A, Noble D, Walz A, Lavé T, Schuler F, Singer T, Polonchuk L. Drug Discov Today. 2016 Jun;21(6):924-38. doi: 10.1016/j.drudis.2016.02.003. Epub 2016 Feb 15. PMID: 26891981 Free PMC article. Review.
- Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events. Ferdinand KC, Botros FT, Atisso CM, Sager PT. Cardiovasc Diabetol. 2016 Feb 24;15:38. doi: 10.1186/s12933-016-0355-z. PMID: 26912057 Free PMC article.
- Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms. Sabol ME, Finkle J, Krucoff M, Stockbridge N, Parkhill N, Shinagawa K, Mahaffey K, Tcheng J, Lenihan D, Melloni C, Todaro T, Michelson E, Munley J, Zander J, Oh R. Ther Innov Regul Sci. 2015 Jul;49(4):511-513. doi: 10.1177/2168479014567319. PMID: 30222439
- Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety ResearchConsortium. Heller S, Darpö B, Mitchell MI, Linnebjerg H, Leishman DJ, Mehrotra N, Zhu H, Koerner J, Fiszman ML, Balakrishnan S, Xiao S, Todaro TG, Hensley I, Guth BD, Michelson EL, Sager P. Am Heart J. 2015 Jul;170(1):23-35. doi: 10.1016/j.ahj.2015.03.007. Epub 2015 Mar 18. PMID: 26093861 Review.
- Novel oral anticoagulants and reversal agents: Considerations for clinical development. Sarich TC, Seltzer JH, Berkowitz SD, Costin' J, Curnutte JT, Gibson CM, Hoffman M, Kaminskas E, Krucoff MW, Levy JH, Mintz PD, Reilly PA, Sager PT, Singer DE, Stockbridge N, Weitz JI, Kowey PR. Am Heart J. 2015 Jun;169(6):751-7. doi: 10.1016/j.ahj.2015.03.010. Epub 2015 Mar 26. PMID: 26027611
- Cardiovascular Safety Outcome Trials: A meeting report from the CardiacSafety Research Consortium. Sager PT, Seltzer J, Turner JR, Anderson JL, Hiatt WR, Kowey P, Prochaska JJ, Stockbridge N, White WB. Am Heart J. 2015 Apr;169(4):486-95. doi: 10.1016/j.ahj.2015.01.007. Epub 2015 Jan 15. PMID: 25819855 Review.
- Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac SafetyResearch Consortium. Seltzer JH, Turner JR, Geiger MJ, Rosano G, Mahaffey KW, White WB, Sabol MB, Stockbridge N, Sager PT. Am Heart J. 2015 Feb;169(2):197-204. doi: 10.1016/j.ahj.2014.11.003. Epub 2014 Nov 10. PMID: 25641528
- Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes. Geiger MJ, Mehta C, Turner JR, Arbet-Engels C, Hantel S, Hirshberg B, Koglin J, Mendzelevski B, Sager PT, Shapiro D, Stewart M, Todaro TG, Gaydos B. Ther Innov Regul Sci. 2015 Jan;49(1):50-64. doi: 10.1177/2168479014549860. PMID: 30222452
- Cardiac Safety Research Consortium: can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward. Darpo B, Garnett C, Benson CT, Keirns J, Leishman D, Malik M, Mehrotra N, Prasad K, Riley S, Rodriguez I, Sager P, Sarapa N, Wallis R. Am Heart J. 2014 Sep;168(3):262-72. doi: 10.1016/j.ahj.2014.06.003. Epub 2014 Jun 6. PMID: 25173536
- Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. Sager PT, Gintant G, Turner JR, Pettit S, Stockbridge N. Am Heart J. 2014 Mar;167(3):292-300. doi: 10.1016/j.ahj.2013.11.004. Epub 2013 Dec 2. PMID: 24576511 Free article.
- Comparison of automated measurements of electrocardiographic intervals and durations by computer-based algorithms of digital electrocardiographs. Kligfield P, Badilini F, Rowlandson I, Xue J, Clark E, Devine B, Macfarlane P, de Bie J, Mortara D, Babaeizadeh S, Gregg R, Helfenbein ED, Green CL. Am Heart J. 2014 Feb;167(2):150-159.e1. doi: 10.1016/j.ahj.2013.10.004. Epub 2013 Oct 17. PMID: 24439975
- The thorough QT study: Is its demise on the horizon? Sager PT, Kowey P. Ann Noninvasive Electrocardiol. 2014 Jan;19(1):1-3. doi: 10.1111/anec.12127. Epub 2014 Jan 8. PMID: 24397828 Free PMC article. No abstract available.
- The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?" Darpo B, Sarapa N, Garnett C, Benson C, Dota C, Ferber G, Jarugula V, Johannesen L, Keirns J, Krudys K, Ortemann-Renon C, Riley S, Rogers-Subramaniam D, Stockbridge N. Ann Noninvasive Electrocardiol. 2014 Jan;19(1):70-81. doi: 10.1111/anec.12128. Epub 2013 Dec 30. PMID: 24372708 Free PMC article. Review.
- Letter to the Editor regarding "Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety ResearchConsortium". Blankfield RP. Am Heart J. 2013 Sep;166(3):e9. doi: 10.1016/j.ahj.2013.06.008. Epub 2013 Jul 16. PMID: 24016520 No abstract available.
- Response to Letter to the Editor by Blankfield regarding "Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium." White WB, Sager PT. Am Heart J. 2013 Sep;166(3):e11. doi: 10.1016/j.ahj.2013.06.007. Epub 2013 Jul 10. PMID: 24016513 No abstract available.
- Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). Hess CN, Rao SV, Kong DF, Aberle LH, Anstrom KJ, Gibson CM, Gilchrist IC, Jacobs AK, Jolly SS, Mehran R, Messenger JC, Newby LK, Waksman R, Krucoff MW. Am Heart J. 2013 Sep;166(3):421-8. doi: 10.1016/j.ahj.2013.06.013. Epub 2013 Jul 23. PMID: 24016489 Free PMC article. Clinical Trial.
- The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical development. Nada A, Gintant GA, Kleiman R, Gutstein DE, Gottfridsson C, Michelson EL, Strnadova C, Killeen M, Geiger MJ, Fiszman ML, Koplowitz LP, Carlson GF, Rodriguez I, Sager PT. Am Heart J. 2013 Apr;165(4):489-500. doi: 10.1016/j.ahj.2013.01.011. Epub 2013 Feb 21. PMID: 23537964 Review.
- Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium. Sager P, Heilbraun J, Turner JR, Gintant G, Geiger MJ, Kowey PR, Mansoor GA, Mendzelevski B, Michelson EL, Stockbridge N, Weber MA, White WB. Am Heart J. 2013 Apr;165(4):477-88. doi: 10.1016/j.ahj.2013.01.002. Epub 2013 Feb 4. PMID: 23537963
- TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. Hess CN, Rao SV, Kong DF, Miller JM, Anstrom KJ, Bertrand OF, Collet JP, Effron MB, Eloff BC, Fadiran EO, Farb A, Gilchrist IC, Holmes DR, Jacobs AK, Kaul P, Newby LK, Rutledge DR, Tavris DR, Tsai TT, White RM, Peterson ED, Krucoff MW. Am Heart J. 2013 Mar;165(3):344-53.e1. doi: 10.1016/j.ahj.2012.09.008. PMID: 23453103 Free PMC article.
- Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction. Christian JB, Finkle JK, Ky B, Douglas PS, Gutstein DE, Hockings PD, Lainee P, Lenihan DJ, Mason JW, Sager PT, Todaro TG, Hicks KA, Kane RC, Ko HS, Lindenfeld J, Michelson EL, Milligan J, Munley JY, Raichlen JS, Shahlaee A, Strnadova C, Ye B, Turner JR. Am Heart J. 2012 Dec;164(6):846-55. doi: 10.1016/j.ahj.2012.09.001. Epub 2012 Oct 26. PMID: 23194484 Free PMC article. Review.
- The Cardiac Safety Research Consortium ECG database. Kligfield P, Green CL. J Electrocardiol. 2012 Nov-Dec;45(6):690-2. doi: 10.1016/j.jelectrocard.2012.07.012. Epub 2012 Sep 19. PMID: 22999491
- Pediatric cardiovascular safety: challenges in drug and device development and clinical application. Bates KE, Vetter VL, Li JS, Cummins S, Aguel F, Almond C, Dubin AM, Elia J, Finkle J, Hausner EA, Joseph F, Karkowsky AM, Killeen M, Lemacks J, Mathis L, McMahon AW, Pinnow E, Rodriguez I, Stockbridge NL, Stockwell M, Tassinari M, Krucoff MW. Am Heart J. 2012 Oct;164(4):481-92. doi: 10.1016/j.ahj.2012.07.019. PMID: 23067905
- Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects. Garnett CE, Zhu H, Malik M, Fossa AA, Zhang J, Badilini F, Li J, Darpö B, Sager P, Rodriguez I. Am Heart J. 2012 Jun;163(6):912-30. doi: 10.1016/j.ahj.2012.02.023. Epub 2012 May 4. PMID: 22709743 Review.
- Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database. Green CL, Kligfield P, George S, Gussak I, Vajdic B, Sager P, Krucoff MW. Am Heart J. 2012 Mar;163(3):365-71. doi: 10.1016/j.ahj.2011.11.009. Epub 2012 Feb 27. PMID: 22424006 Free PMC article. Clinical Trial.
- Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration. Newby LK, Rodriguez I, Finkle J, Becker RC, Hicks KA, Hausner E, Chesler R, Harper C, Targum S, Berridge BR, Lewis E, Walker DB, Dollery C, Turner JR, Krucoff MW. Am Heart J. 2011 Jul;162(1):64-73. doi: 10.1016/j.ahj.2011.04.005. PMID: 21742091 Review.
- The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing. Kligfield P, Green CL, Mortara J, Sager P, Stockbridge N, Li M, Zhang J, George S, Rodriguez I, Bloomfield D, Krucoff MW. Am Heart J. 2010 Dec;160(6):1023-8. doi: 10.1016/j.ahj.2010.09.002. Epub 2010 Sep 2. PMID: 21146653 Review.
- Electrocardiographic assessment for therapeutic proteins--scientific discussion. Rodriguez I, Erdman A, Padhi D, Garnett CE, Zhao H, Targum SL, Balakrishnan S, Strnadova C, Viner N, Geiger MJ, Newton-Cheh C, Litwin J, Pugsley MK, Sager PT, Krucoff MW, Finkle JK. Am Heart J. 2010 Oct;160(4):627-34. doi: 10.1016/j.ahj.2010.07.001. PMID: 20934555 Review.
- Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac SafetyResearch Consortium "Incubator" Think Tank. Al-Khatib SM, Calkins H, Eloff BC, Kowey P, Hammill SC, Ellenbogen KA, Marinac-Dabic D, Waldo AL, Brindis RG, Wilbur DJ, Jackman WM, Yaross MS, Russo AM, Prystowsky E, Varosy PD, Gross T, Pinnow E, Turakhia MP, Krucoff MW. Am Heart J. 2010 Oct;160(4):619-26. doi: 10.1016/j.ahj.2010.06.044. PMID: 20934554 Review.
- Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development. Min SS, Turner JR, Nada A, DiMino TL, Hynie I, Kleiman R, Kowey P, Krucoff MW, Mason JW, Phipps A, Newton-Cheh C, Pordy R, Strnadova C, Targum S, Uhl K, Finkle J. Am Heart J. 2010 May;159(5):716-29. doi: 10.1016/j.ahj.2010.02.004. PMID: 20435178 Review.
- Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac SafetyResearch Consortium "Incubator" Think Tank. Al-Khatib SM, Calkins H, Eloff BC, Packer DL, Ellenbogen KA, Hammill SC, Natale A, Page RL, Prystowsky E, Jackman WM, Stevenson WG, Waldo AL, Wilber D, Kowey P, Yaross MS, Mark DB, Reiffel J, Finkle JK, Marinac-Dabic D, Pinnow E, Sager P, Sedrakyan A, Canos D, Gross T, Berliner E, Krucoff MW. Am Heart J. 2010 Jan;159(1):17-24. doi: 10.1016/j.ahj.2009.10.018. PMID: 20102862 Review.
- Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative. Piccini JP, Whellan DJ, Berridge BR, Finkle JK, Pettit SD, Stockbridge N, Valentin JP, Vargas HM, Krucoff MW; CSRC/HESI Writing Group. Am Heart J. 2009 Sep;158(3):317-26. doi: 10.1016/j.ahj.2009.06.007. Epub 2009 Jul 23. PMID: 19699852